Look around – what do you see? Empowered patients, remote monitoring and care, platform technologies, personalized and preventative health, AI, machine learning and advanced analytics, virtual engagement, decentralized trials, telehealth, cell and gene therapy commercialization… the list goes on.
Pharma is undergoing a period of unrivaled change. To lead the path forward we must move beyond normal, setting new boundaries for partnerships across healthcare and implementing operating models that aren’t just resilient, but ensure a sustained cultural shift toward authenticity and agility. To help you with this transformation, we are bringing together 4 pharma USA leaders to show you how you can move beyond pharma to shape the future of health – heralding an era of true collaboration and the delivery of seamless, personalized experiences for every patient and HCP.
Attend this Reuters Events leadership briefing and find out:
- How pharma is preparing for the next frontier of preventative medicine
- What pharma leaders are doing to prepare for healthcare’s next crisis, post-COVID
- How agility and speed are key differentiators for pharma’s commercial operations
- The approach pharma leaders are taking to democratize and personalize healthcare for every patient
- David Fredrickson, EVP Oncology Business Unit, AstraZeneca
- Kabir Nath, President and CEO, Otsuka US
- Arnaud Robert, EVP Chief Digital Officer, Sanofi
- Deborah Waterhouse, CEO, ViiV Healthcare
- Elaine O’Hara, Chief Commercial Officer, Sanofi Pasteur
Don’t miss out on this unique opportunity to hear from pharma USA innovators and leaders.